Diagnosis of myocardial injury by biochemical markers: Problems and promises

Cardiology in Review

Volumn 10, Issue 5, 2002, Pages 306-317

  Malasky, Beth R ^a   Alpert, Joseph S ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Acute coronary syndromes; Acute myocardial infarction; Cardiac enzymes; Creatine kinase; Troponins

Indexed keywords

ANTINEOPLASTIC AGENT; BIOCHEMICAL MARKER; CREATINE KINASE MB; MYOGLOBIN; TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; ARTICLE; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CATHETER ABLATION; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DIAGNOSTIC VALUE; DIALYSIS; DRUG MEGADOSE; HIGH RISK POPULATION; HUMAN; KIDNEY FAILURE; LUNG EMBOLISM; PERICARDITIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0036732874     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045415-200209000-00007     Document Type: Article

References (87)

1. A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
2. Joint efforts across national boundaries between professional organizations in cardiovascular medicine: One way into the future
3. Biochemical markers of myocardial injury: ts MB creatine kinase the choice for the 1990s?
4. Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction
5. Pandora's box is torn asunder
6. Ruling out acute myocardial infarction early with two serial creatine kinase-MB mass determinations
7. Diagnostic marker cooperative study for the diagnosis of myocardial infarction
8. Clinical and angiographic correlates of normal creatine kinase with increased MB isoenzymes in possible acute myocardial infarction
9. Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation
10. Value of additional two-hour myoglobin for the diagnosis of myocardial infarction in the emergency department
11. Functional significance of alterations in cardiac contractile protein isoforms
12. The troponins
13. Cardiac troponin and β-type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis
14. Expression of cardiac troponin T isoforms in skeletal muscle of renal disease patients will not cause false-positive results by the second-generation cardiac troponin T assay
15. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction
16. Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex
17. The acute coronary syndrome diagnosis and prognostic evaluation by troponin I is influenced by the test system affinity to different troponin complexes
18. False positive analytical interference of cardiac troponin I assays: An important consideration for method selection
19. Biochemical differences between cTnT and cTnI and their significance for diagnosis of acute coronary syndromes
20. Cardiac troponin I: A marker with high specificity for cardiac injury
21. National Academy of Clinical Biochemistry standards of laboratory practice: Recommendations for the use of cardiac markers in coronary artery diseases
22. Evaluation of a rapid bedside assay for detection of serum cardiac troponin T
23. Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction
24. Troponin T: A diagnostic marker for myocardial infarction and minor cardiac cell damage
25. Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies
26. Epidemiologic classification of acute myocardial infarction: Time for a change?
27. Troponin T or troponin I or CK-MB (or none?)
28. Cardiac troponin: See ya later, CK!
29. Risk stratification with cardiac troponin I in acute coronary syndromes
30. It's time for a change to a troponin standard
31. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes
32. Prognostic significance of admission troponin T concentrations in patients with myocardial infarction
33. Measurement of cardiac troponin I levels in the emergency department: Predictive value for cardiac and all-cause mortality
34. Elevated cardiac troponin I predicts a high-risk angiographic anatomy of the culprit lesion in unstable angina
35. Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: Angiographic correlates and long-term clinical outcomes
36. Direct comparison of early elevations of cardiac troponin T and I in patients with clinical unstable angina
37. Cardiac troponin T as a marker for myocardial ischemia in patients seen at the emergency department for acute chest pain
38. Cardiac troponin T levels for risk stratification in acute myocardial ischemia
39. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: Results from a randomized trial
40. Troponins in acute coronary syndromes; more TACTICS for an early invasive strategy
41. Invasive compared with non-invasive treatment of unstable coronary-artery disease: FRISC II prospective randomized multicentre study
42. Interpreting new treatment guidelines for non-ST-segment elevation acute coronary syndromes
43. Missed diagnoses of acute cardiac ischemia in the emergency department
44. Six-hour versus 12-hour protocols for AMI: CK-MB in conjunction with myoglobin
45. Accuracy of biomarkers to diagnose acute cardiac ischemia in the emergency department: A meta-analysis
46. Use of troponin T and creatine kinase-MB subunit levels for risk stratification of emergency department patients with possible myocardial ischemia
47. Evaluation of the patient with "rule out myocardial infarction"
48. Comparison of troponin T versus creatine kinase-MB in suspected acute coronary syndromes
49. Cardiac troponin I and creatine kinase-MB mass to rule out myocardial injury in hospitalized patients with renal insufficiency
50. Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: A case-matched study
51. A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a veteran's hospital: A pilot study
52. Cardiac troponin T predicts mortality in patients with end-stage renal disease
53. Specificity of cardiac troponin I and creatine kinase-MB isoenzyme in asymptomatic long-term hemodialysis patients and effect of hemodialysis on these cardiac markers
54. Cardiac troponin T predicts long-term outcomes in hemodialysis patients
55. Cardiac troponin I as diagnostic and prognostic marker in severe heart failure
56. Cardiac troponins in congestive heart failure
57. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes
58. A novel biochemical approach to congestive heart failure: Cardiac troponin T
59. Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain
60. Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions
61. Minimal myocardial damage during coronary intervention is associated with impaired outcome
62. Relation between coronary atherosclerotic plaque burden and cardiac enzyme elevation following percutaneous coronary intervention
63. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality
64. Long-term clinical events following creatine kinase-myocardial band isoenzyme elevation after successful coronary stenting
65. Prognostic value of cardiac troponin I levels following catheter-based coronary interventions
66. Frequency and prognostic value of cardiac troponin I elevation after coronary stenting
67. Prognostic value of cardiac troponin I re-elevation following percutaneous coronary intervention in high-risk patients with acute coronary syndromes
68. Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous coronary angioplasty with or without stenting
69. Periprocedural cardiac marker elevation after percutaneous coronary artery revascularization: Importance and implications
70. Usefulness of cardiac troponin I in patients undergoing open heart surgery
71. Troponin I, troponin T, or creatine kinase-MB to detect perioperative myocardial damage after coronary artery bypass surgery
72. Troponin levels in patients with myocardial infarction after coronary artery bypass grafting
73. Cardiac troponin I release after open heart surgery: A marker of myocardial protection?
74. Postoperative troponin I values: Insult or injury?
75. Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis
76. Prognostic value of clinical markers of reperfusion in patients with acute myocardial infarction treated by thrombolytic therapy
77. Bedside markers of coronary artery patency and short-term prognosis of patients with acute myocardial infarction and thrombolysis
78. Rapid diagnosis of coronary reperfusion by measurement of myoglobin level every 15 min in acute myocardial infarction
79. Myoglobin, creatine kinase-MB and cardiac troponin I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction
80. Plasma levels of cardiac troponin I after prolonged strenuous endurance exercise
81. Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy
82. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage
83. Circulating cardiac troponin I in acute pericarditis
84. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction
85. Evaluation of myocardial injury following repeated internal atrial shocks by monitoring serum cardiac troponin I levels
86. Detection of myocardial injury during radiofrequency catheter ablation by measuring serum cardiac troponin I levels: Procedural correlates